Antibody Engineering & Therapeutics US is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Nathan Thomsen
Senior Research Scientist II at Gilead Sciences

Profile

Nathan joined Gilead in 2014 and has played a leading role in establishing antibody engineering capabilities at Gilead Sciences.  Nathan's research group supports project teams across therapeutic areas, and since 2016 he has served as both a research and development project team lead for Gilead's HIV broadly neutralizing antibody program. Before joining Gilead, Nathan was a Damon Runyon Postdoctoral Fellow with Jim Wells at UC San Francisco and earned a Ph.D. in structural biology with James Berger at UC Berkeley.

Nathan Thomsen's Network

Agenda Sessions

  • Engineering Effector Enhanced HIV Broadly Neutralizing Antibodies for HIV Cure

    ,